PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 135.00
+6.00 (4.65%)
Jun 24, 2026, 3:30 PM JST
PRISM BioLab Co.,LTD Market Cap
PRISM BioLab Co.,LTD has a market cap or net worth of 4.77 billion as of June 24, 2026. Its market cap has decreased by -50.37% in one year.
Market Cap
4.77B
Enterprise Value
2.31B
Revenue
711.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
135.00
Market Cap Chart
Since July 2, 2024, PRISM BioLab Co.,LTD's market cap has decreased from 17.84B to 4.77B, a decrease of -73.27%. That is a compound annual growth rate of -48.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 4.99B | -13.35% |
| Dec 30, 2025 | 5.76B | -44.77% |
| Dec 30, 2024 | 10.43B | -41.56% |
| Jul 2, 2024 | 17.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Carna Biosciences | 6.59B |
| Soiken Holdings | 6.33B |
| BrightPath Biotherapeutics | 6.11B |
| CellSource | 5.87B |
| Noile-Immune Biotech | 5.12B |
| Chiome Bioscience | 5.05B |
| Kohjin Bio | 4.92B |
| Linical | 4.72B |